Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 12, 1996, Pages 4492-4495

  Mogul, Harriette R ^a   Marshall, Merville ^a   Frey, Michael ^a   Burke, Harry B ^a   Wynn, Pe Shein ^a   Wilker, Simone ^a   Southren, A Louis ^a   Gambert, Steven R ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SYNDROME X;

BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MENOPAUSE; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS;

ANIMALIA;

EID: 0029797870     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.12.4492     Document Type: Article

References (26)

1. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Molt DM, Bennett PH. 1989. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet i:1356-1359.
2. Reaven GM. Role of insulin resistance in human disease. 1988. Diabetes 37:1595-1607.
3. DeFronzo RA, Ferrannini E. 1991. Insulin resistance, a multifaceted syndrome responsible for NIDDM, obesity, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194.
4. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M. 1988. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266-272.
5. Lee PDK, Conover CA, Powell DR. 1993. Minireview: Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Experiment Biol Metab. 204:4-29.
6. Levitt Katz LE, Rosenfield RG, Cohen SP. 1995. Clinical significance of insulin-like growth factor binding proteins (IGFBP's) The Endocrinologist 5:36-43.
7. Orlowski CC, Ooi GT, Brown DR, Yang YW-H, Tseng LY-H, Rechler MM. 1991. Insulin rapidly inhibits insulin-like growth factor binding protein-1 gene expression in H4-II-E rat hepatoma cells Molecular Endocrinol 5:1180-1187
8. Ooi GT, Tseng L Y-H, Tran MQ, Rechler MM. 1992. Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozocin-diabetic rats. Molecular Endocrinol 6:2219-2228.
9. Conover CC, Lee PDK, Kanaley JA, Clarkson JT, Jensen MD. 1992 Insulin regulation of insulin-like binding protein-1 in obese and non-obese humans. J Clin Endocrinol Metab 71:1355-1360
10. Lee PDK, Jensen MD, Divertie GD, Heiling VJ, Katz HH, Conover CC. 1993. Insulin-like growth factor-binding protein-1 response to insulin during suppression of endogenous insulin secretion. Metabolism 42: 409-414.
11. Suikkari A, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H. 1989. Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab 68:135-140.
12. Conover C, Butler PC, Wang M, Rizza RA, Lee PDK. 1990. Lack of growth hormone effect on insulin-associated suppression of insulin-like growth factor binding protein 1 in humans. Diabetes 39:1251-1256.
13. Weaver JU, Holly JMP, Kopelman PG et al. 1990. Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clin Endocrinol 33:415-422
14. Suikkari AM, Ruutiainen K, Eerkkola R, Seppala M. 1989. Low levels of low molecular weight insulin-like growth factor binding protein in patients with polycystic ovarian disease. Hum Reprod 4:136-139.
15. Pekonen F, Laatikainen T, Buyalos R, Rutanen EM. 1989. Decreased 34K insulin-like growth factor binding protein in polycystic ovary disease. Fertil Steril 51:972-975.
16. Lee PDK, Mathew G, Levitsky I, Powell D, Argente J. 1994. Characterization of a new, highly-specific and sensitive immunoradiometric assay (IRMA). Growth Regulation 4 (suppl 1): 139.
17. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057.
18. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. 1988. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 315:220-224.
19. Wing RR, Matthews KA, Kuller LH et al. 1992. Environmental and familial contributions to insulin levels and change in insulin levels in middle-aged women. JAMA:268:1890-1895.
20. Suzuki M, Ikebuchi M, Shinozaki K et al. 1996. Mechanism and clinical implication of insulin resistance syndrome. Diabetes 45 (Suppl.3):S52-S54.
21. . Kleinbaum DG, Kupper LL, Muller KE. 1988. Applied regression analysis and other multivariable methods. Confounding and interaction in regression (Chapter 11). Boston:PWS Kent; 164.
22. Gibson JM, Westwood M, Young RF, White A. 1996. Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM). J Clin Endocrinol Metab 81:860-863.
23. Sobel BE. 1996. Potentiation of vasculopathy by insulin. Implications from an NHLBI Clinical Alert. Circulation 93:1613-1615.
24. Colditz GA, Willett WC, Rotnitzky A, Manson JE. 1995. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Int Med 122:481-486.
25. Manson JE, Willett WC, Stampfer MJ et al. 1995. Body weight and mortality among women. N Engl J Med 333:677-685.
26. Rose G, Parker DJP. 1978. Epidemiology for the Uninitiated: Screening. Br Med J 2:1417-1418.